Srivar Pharma Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 20.00 Cr
- Company Age 15 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.58 Cr
- Satisfied Charges ₹ 5.00 Cr
- Revenue Growth -7.29%
- Profit Growth -71.69%
- Ebitda 172.11%
- Net Worth 85.87%
- Total Assets 34.30%
About Srivar Pharma
Srivar Pharma Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 September 2009 and has a history of 15 years and four months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Dsr Labs Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 20.00 Cr.
The company currently has active open charges totaling ₹8.58 Cr. The company has closed loans amounting to ₹5.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ramakrishnan Sishtla and Prabhavathi Sistla serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100TG2009PTC064986
-
Company No.
064986
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Sep 2009
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Srivar Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramakrishnan Sishtla
|
Managing Director | 05-Oct-2017 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Prabhavathi Sistla
|
Whole-Time Director | 05-Oct-2017 | Current |
Financial Performance of Srivar Pharma.
Srivar Pharma Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 7.29% decrease. The company also saw a substantial fall in profitability, with a 71.69% decrease in profit. The company's net worth Soared by an impressive increase of 85.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Srivar Pharma?
In 2022, Srivar Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Shreegen Pharma LimitedRamakrishnan Sishtla is a mutual person
-
Aalto Biotech Private LimitedRamakrishnan Sishtla and Prabhavathi Sistla are mutual person
-
Vidur Human Care Private Limited
Ramakrishnan Sishtla and Prabhavathi Sistla are mutual person
-
Syngreen Lifesciences Private Limited
Ramakrishnan Sishtla is a mutual person
-
Hakue Labs Private Limited
Ramakrishnan Sishtla and Prabhavathi Sistla are mutual person
-
Varydos Biotech Private Limited
Prabhavathi Sistla is a mutual person
Charges (Loans)
₹8.58 Cr
₹5.00 Cr
Charges Breakdown by Lending Institutions
- Others : 8.58 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jun 2022 | Others | ₹5.80 M | Open |
| 15 Mar 2022 | Others | ₹8.00 Cr | Open |
| 20 Jul 2015 | Andhra Pradesh State Financial Corporation | ₹1.61 Cr | Satisfied |
| 27 Jun 2013 | Andhra Pradesh State Financial Corporation | ₹3.39 Cr | Satisfied |
How Many Employees Work at Srivar Pharma?
Srivar Pharma has a workforce of 20 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Srivar Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srivar Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
